Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;12(6):100130.
doi: 10.1016/j.tjpad.2025.100130. Epub 2025 Mar 12.

Lifestyle factors and plasma biomarkers of Alzheimer's disease: A narrative review

Affiliations
Review

Lifestyle factors and plasma biomarkers of Alzheimer's disease: A narrative review

Claudie Hooper et al. J Prev Alzheimers Dis. 2025 Jun.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterised by amyloid-β (Aβ), tau hyperphosphorylation and neurodegeneration. Blood-based biomarkers are emerging as a minimally invasive tool for disease detection and monitoring. This review depicts the relationships between modifiable lifestyle factors (nutrition, physical activity (PA), sleep, alcohol consumption, smoking, and social isolation) and plasma biomarkers of AD: Aβ42, Aβ40, Aβ42/40, phosphorylated tau, total tau, neurofilament light chain (NfL) and glial fibrillary acidic protein. Limited evidence suggests that better nutrition is associated with favourable AD plasma biomarker profiles and that PA is associated with less plasma NfL and Aβ, whilst poor sleep is associated with elevated plasma Aβ. However, lack of data and inconsistent findings highlight the need for further investigation to substantiate or refute these trends. Moreover, future research should include the analysis of lifestyle on plasma biomarkers according to gender, metabolic health and APOE status. Considering the growing emphasis on modifiable lifestyle factors for preventing and delaying dementia onset further investigation is justified.

Keywords: Alzheimer's disease; Biomarkers; INSPIRE; Lifestyle; Plasma.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. 2023 Alzheimer's disease facts and figures. Alzheimer Dement 2023;19:1598–695. 10.1002/alz.13016. - DOI - PubMed
    1. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci. 1991;12:383–388. doi: 10.1016/0165-6147(91)90609-V. - DOI - PubMed
    1. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256:184–185. doi: 10.1126/science.1566067. - DOI - PubMed
    1. Jack C.R., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., et al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimer Dement. 2018;14:535–562. doi: 10.1016/j.jalz.2018.02.018. - DOI - PMC - PubMed
    1. Leuzy A., Mattsson-Carlgren N., Palmqvist S., Janelidze S., Dage J.L., Hansson O. Blood-based biomarkers for Alzheimer's disease. EMBO Mol Med. 2022;14:e14408. doi: 10.15252/emmm.202114408. - DOI - PMC - PubMed